This report on the global biosimilars market studies the past as well as current growth trends and opportunities to gain valuable insights of the same indicators for the said market during the forecast period of 2019 to 2027.The report provides the overall market revenue of the global biosimilars market for the period 2017–2027, considering 2018 as the base year and 2027 as the forecast year.
The report also provides the compound annual growth rate (CAGR) for the global biosimilars market for the forecast period.
The report has been prepared after an extensive research.Primary research involves bulk of research efforts, wherein analysts carried out interviews with industry leaders and opinion makers.
Extensive secondary research involves referring to key players’ product literature, annual reports, press releases, and relevant documents to understand the global biosimilars market.
Secondary research also includes Internet sources, statistical data from government agencies, websites, and trade associations. Analysts have also employed a combination of the top-down and bottom-up approaches to study various phenomena in the global biosimilars market.
The report includes an elaborate executive summary, along with a snapshot of the growth behavior of various segments and sub-segments included in the scope of the study.Additionally, the report sheds light on the changing competitive dynamics in the global biosimilars market.
These indices serve as valuable tools for existing market players as well as for entities interested in participating in the global biosimilars market. The next section of the global biosimilars report highlights the USPs, which include regulatory scenarios for biosimilars globally, Biosimilars pipeline analysis, and potential product launches in the global biosimilars market.
The report delves into the competitive landscape of the global biosimilars market.Key players operating in the global biosimilars market have been identified, and each one of these has been profiled for their distinguishing business attributes.
Company overview, financial standings, recent developments, and SWOT are some of the attributes of players profiled in the global biosimilars market report.
Key Questions Answered in Biosimilars Market Report
What is the sales/revenue generated by biosimilar products across all regions during the forecast period?
What are the key trends in the biosimilars market?
What are the major drivers, restraints, and opportunities in the market?
In which region is the biosimilars market set to expand at the fastest CAGR during the forecast period?
Which segment will have the highest revenue globally in 2027 and which product segment will expand at the fastest CAGR during the forecast period?
Biosimilars Market - Research Objectives and Research Approach
The comprehensive report on the global biosimilars market begins with an overview of the said market, followed by the scope and objectives of the study.Following this, the report provides detailed explanation of the objectives of this study and healthcare compliances laid down by accredited agencies in the purview of research in the biosimilars market.
It is followed by market introduction, market dynamics, and an overview of the biosimilars market, which includes analysis of market drivers, restraints, and trends affecting the growth of the market.Furthermore, Y-o-Y analysis with elaborate insights has been provided to understand the Y-o-Y trends of the biosimilars market.
The next section of the biosimilars report highlights the USPs, which include regulatory scenarios for biosimilars globally, biosimilars pipeline analysis, and key product launches in the global market.
For reading comprehensibility, the report has been compiled in a chapter-wise layout, with each section further divided into small sections.The entire report comprises an exhaustive collection of graphs and tables that are appropriately interspersed in the entire compilation.
Pictorial representation of actual and projected values of key segments is visually appealing to readers. This also allows comparison of the market shares of key segments in the past and at the end of the forecast period.
Revenue generated by key biosimilars market manufacturers have been mapped to ascertain the size of the global biosimilars market in terms of value.The forecast presented here assesses the total revenue generated in the biosimilars market.
In order to provide an accurate forecast, we initiated by sizing up the current biosimilars market with the help of the parent market.
The report analyzes the biosimilars market in terms of product, indication, and region.Key segments under each criteria have been studied at length, and the market share for each of these at the end of 2027 has been provided.
These valuable insights would help market stakeholders in making informed business decisions for investments in the biosimilars market.
Our reports have been used by over 10K customers, including:
175 pages •
By The Business Research Company
• Apr 2021
Major players in the oral biologics and biosimilar market are Novartis, Rani Therapeutics, Eli Lilly and Co., AstraZeneca plc, Novo Nordisk A/S, Biocon Limited, Oramed Pharmaceuticals, BiosanaPharma, Entera Bio Ltd. and Allergan plc. The global oral biologics & biosimilar drugs market is expected to grow from $3.53 billion in 2020 to...
212 pages •
By Global Industry Analysts
• Apr 2021
- Global Healthcare Cold Chain Logistics Market to Reach $18.5 Billion by 2027
- Amid the COVID-19 crisis, the global market for Healthcare Cold Chain Logistics estimated at US$11.3 Billion in the year 2020, is projected to reach a revised size of US$18.5 Billion by 2027, growing at a CAGR of 7.3% over the...
The Global Antibody Partnering Terms and Agreements 2014 to 2021 report provides comprehensive understanding and unprecedented access to the Antibody partnering deals and agreements entered into by the worlds leading healthcare companies. The report provides a detailed understanding and analysis of how and why companies...
The Formulation Development Outsourcing market was valued at approximately USD 8,055 million in 2020 and is expected to witness a revenue of USD 12,650 million in 2026, with a CAGR of 7.2% over the forecast period. The rapidly evolving threat of COVID-19 is impacting lives, communities, businesses, and industries around the world. The...
200 pages •
By The Business Research Company
• Dec 2020
Major players in the pegfilgrastim biosimilars market are Mylan, Biocon, Mundipharma, Pfizer, Sandoz, Coherus, Intas Pharmaceuticals and Fresenius Kabi. The global pegfilgrastim biosimilar market is expected to decline from $534.43 million in 2019 to $453.11 million in 2020 at a compound annual growth rate (CAGR) of -15.22%. The decline...
The global cell isolation market size is projected to reach USD 15.0 billion by 2025 from USD 6.9billion in 2020, at a CAGR of 16.8% during the forecast period. Market growth is driven by factors The growing investments in personalized medicine can primarily be attributed to the growing demand for advanced treatments with minimal side-effects...
131 pages •
By Global Industry Analysts
• Apr 2021
- Global Lysosomal Storage Diseases Market to Reach $10.3 Billion by 2027
- Amid the COVID-19 crisis, the global market for Lysosomal Storage Diseases estimated at US$7 Billion in the year 2020, is projected to reach a revised size of US$10.3 Billion by 2027, growing at a CAGR of 5.6% over the analysis period...
Readers of one of the analyst’s media partners were invited to participate in an online survey in September 2020 that centered on the state of their laboratories in 2020 and their expectations for 2021.The analyst has conducted similar studies among the same targeted respondents since 2012.
Where applicable, the study presents year-over-year...
The anti-money laundering solution market was valued at US$ 1,503.99 million in 2019 and is projected to reach US$ 5,866.51 million by 2027; it is expected to grow at a CAGR of 16.2% from 2020 to 2027. Transaction monitoring is a crucial procedure and key control in anti-money laundering (AML) and countering the financing of terrorism (AML/CFT)...
The global recombinant proteins market is projected to reach USD 1.7billion by 2026 from USD 1.0billion in 2021, at a CAGR of 9.8% during the forecast period. The market growth is primarily driven by factors such as increasing government investments and R&D expenditure in pharmaceutical & biotechnology companies, growing industryacademia collaborations,...
You can change your Cookie Settings at any time but parts of our site will not function correctly without them.